Norris Medicines informs about outcome of board meeting

13 Feb 2023 Evaluate
Norris Medicines has informed that the Board of Directors at their Meeting held on 13th February, 2023, has approved the Unaudited financial results for the Quarter and nine months ended 31st December 2022. As per Regulation 33 of Listing Regulations, the Financial Results and Limited Review Report are enclosed for records. The Meeting of the Board of Directors concluded at 12:30 PM.

The above information is a part of company’s filings submitted to BSE.

Norris Medicines Share Price

15.00 -0.50 (-3.23%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×